196 related articles for article (PubMed ID: 22106726)
1. Large facial basal cell carcinoma treated with multimodal combination therapy.
Rubenzik MK; Schwartz LR; Humphreys TR
Cutis; 2011 Oct; 88(4):182-4. PubMed ID: 22106726
[TBL] [Abstract][Full Text] [Related]
2. Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases.
Thissen MR; Kuijpers DI; Krekels GA
J Drugs Dermatol; 2006 May; 5(5):461-4. PubMed ID: 16703785
[TBL] [Abstract][Full Text] [Related]
3. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma.
Torres A; Niemeyer A; Berkes B; Marra D; Schanbacher C; González S; Owens M; Morgan B
Dermatol Surg; 2004 Dec; 30(12 Pt 1):1462-9. PubMed ID: 15606733
[TBL] [Abstract][Full Text] [Related]
4. Treatment of nodular basal cell carcinoma with cryotherapy and reduced protocol of imiquimod.
Moutran R; Maatouk I; Stephan F; Tomb R
Cutis; 2012 Nov; 90(5):256-7. PubMed ID: 23270198
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study.
Butler DF; Parekh PK; Lenis A
Dermatol Surg; 2009 Jan; 35(1):24-9. PubMed ID: 19018814
[TBL] [Abstract][Full Text] [Related]
6. Immunocryosurgery for non-superficial basal cell carcinoma: a pro-spective, open-label phase III study for tumours ≤ 2 cm in diameter.
Gaitanis G; Bassukas ID
Acta Derm Venereol; 2014 Jan; 94(1):38-44. PubMed ID: 23722308
[TBL] [Abstract][Full Text] [Related]
7. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
[TBL] [Abstract][Full Text] [Related]
9. Cryoimmunotherapy: superficial basal cell cancer and squamous cell carcinoma in situ treated with liquid nitrogen followed by imiquimod.
MacFarlane DF; El Tal AK
Arch Dermatol; 2011 Nov; 147(11):1326-7. PubMed ID: 22106125
[No Abstract] [Full Text] [Related]
10. Clinical efficacy of Mohs surgery combined with topical photodynamic therapy for facial basal cell carcinoma.
Zhang J; Lu Y; Zhang X; Yang Y; Kou H; Wang Y
J Cancer Res Ther; 2020 Sep; 16(5):1051-1055. PubMed ID: 33004746
[TBL] [Abstract][Full Text] [Related]
11. Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report.
Rigel DS; Torres AM; Ely H
J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s15-6. PubMed ID: 18277458
[TBL] [Abstract][Full Text] [Related]
12. Current modalities and new advances in the treatment of basal cell carcinoma.
Ceilley RI; Del Rosso JQ
Int J Dermatol; 2006 May; 45(5):489-98. PubMed ID: 16700779
[TBL] [Abstract][Full Text] [Related]
13. Rapid wound re-epithelialization and basal cell carcinoma clearance after Mohs micrographic surgery with postoperative photodynamic therapy.
Reddy KK; Hanke CW; Tierney EP
J Drugs Dermatol; 2010 Feb; 9(2):143-8. PubMed ID: 20214177
[TBL] [Abstract][Full Text] [Related]
14. Cryosurgery during Imiquimod (Immunocryosurgery) for Periocular Basal Cell Carcinomas: An Efficacious Minimally Invasive Treatment Alternative.
Gaitanis G; Kalogeropoulos CD; Bassukas ID
Dermatology; 2016; 232(1):17-21. PubMed ID: 26583773
[TBL] [Abstract][Full Text] [Related]
15. Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series.
Huber A; Huber JD; Skinner RB; Kuwahara RT; Haque R; Amonette RA
Dermatol Surg; 2004 Mar; 30(3):429-30. PubMed ID: 15008876
[TBL] [Abstract][Full Text] [Related]
16. A 36-month clinical experience of the effectiveness of curettage and imiquimod 5% cream in the treatment of basal cell carcinoma.
Tillman DK; Carroll MT
J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s7-14. PubMed ID: 18277457
[TBL] [Abstract][Full Text] [Related]
17. Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream.
Ezughah FI; Affleck AG; Evans A; Ibbotson SH; Fleming CJ
J Dermatolog Treat; 2008; 19(3):156-8. PubMed ID: 18569271
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas.
Garcia-Martin E; Idoipe M; Gil LM; Pueyo V; Alfaro J; Pablo LE; Zubiri ML; Fernandez J
J Ocul Pharmacol Ther; 2010 Aug; 26(4):373-9. PubMed ID: 20698800
[TBL] [Abstract][Full Text] [Related]
19. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
Cohen PR; Schulze KE; Nelson BR
Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
[TBL] [Abstract][Full Text] [Related]
20. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
Vidal D; Matías-Guiu X; Alomar A
Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]